Upregulation of Ppp1r1b is associated with gastric, breast, colon, esophageal, lung, and prostate cancers (Avanes et al., 2019), and correlates to worse survival outcomes in pancreatic cancer (Tiwari et al., 2020). This evidence concerns the gene PPP1R1B and familial pancreatic carcinoma.